Fundamentals - Ratios

Snapshot | Trading Statistics | Balance Sheet | Income Statement | Cash Flow | Ratios
All financial information has been updated to reflect the results of the global pharmaceuticals business as discontinued operations, consistent with the current presentation in our Form 8-K filed with the U.S. S.E.C on January 29, 2010.
Valuation
P/E (TTM)18.22
Price to Revenue (TTM)2.26
Price to Cash Flow (TTM)12.52
Price to Book (MRQ)2.70
Per Share
Revenue/Share (TTM)22.91
EPS Fully Diluted (TTM)3.36
Dividend/Share (TTM)1.76
Book Value/Share (MRQ)23.07
Cash Flow/Share (TTM)4.13
Cash (MRQ)1.70
Profitability
Operating Margin (TTM) (%)21.07
Net Profit Margin (TTM) (%)14.19
Gross Margin (TTM) (%)51.89
Growth
5 Year Annual Growth (%)5.78
5 Year Annual Revenue Growth Rate (%)8.33
5 Year Annual Dividend Growth Rate (%)12.01
5 Year EPS Growth (%)9.49
Financial Strength
Quick Ratio (MRQ).63
Current Ratio (MRQ).92
LT Debt to Equity (MRQ) (%)34.53
Total Debt to Equity (MRQ) (%)45.12
Management Effectiveness
Return on Equity (TTM) (%)17.47
Return on Assets (TTM) (%)8.35
Return on Investment (TTM) (%)10.61
Efficiency
Asset Turnover (TTM).59
Inventory Turnover (TTM)5.23
FY = Fiscal Year MRQ = Most Recent Quarter
mil = Millions TTM = Trailing Twelve Months
Powered by Thomson Reuters